好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Five-Year Follow-Up on Temporal Lobectomy in Temporal Lobe Epilepsy: A Single-Center Experience in LATAM
Epilepsy/Clinical Neurophysiology (EEG)
S20 - Epilepsy Clinical Outcomes and Prognostication (4:54 PM-5:06 PM)
008
TLE is the most common form of focal epilepsy and a frequent cause of drug-resistant epilepsy (DRE), making temporal lobectomy (TL) an effective therapeutic option.

Compare postoperative outcomes in terms of five-year seizure freedom in patients with temporal lobe epilepsy (TLE) who underwent epilepsy surgery.

Observational, descriptive, and cross-sectional study in patients with TLE treated at the Epilepsy Clinic at a Neurological Hospital in Mexico. SPSS® 29 was used for the analysis. Quantitative variables were expressed as mean and standard deviation and analyzed using the Student's t-test or a non-parametric equivalent. Qualitative variables were expressed as frequencies and percentages and analyzed using Pearson's Chi-square or Fisher's exact tests.


A total of 89 patients were included, 53 (59.6%) were female and had a mean age of 36.13 years (IQR: 28, 42). Anterior temporal lobectomy (ATL) was performed in 64 (71.91%) patients, amygdalohippocampectomy in 15 (16.9%) patients, parahippocampectomy in 5 (5.6%) patients, and lesionectomy in 5 (5.6%)  patients.  Mean number of preoperative seizures was 11.0 ± 10.02 (1-60), and postoperative seizures were 1.2 ± 2.97 ( 0-19), with significant differences between them (p>0.001). There was a significant reduction (p>0.001) in the number of antiseizure medications (ASM).  Regarding seizure freedom, 59 (66.29%) patients were in Engel class I during the first and second years, 60 (67.4%) in the third year, and 58 (65.1%) in the fourth and fifth years.  Considering the type of surgery and seizure freedom, it was found that during the 1-3 year follow-up period, there was no significant difference (p=0.06), but in the 4th and 5th years, patients who underwent amygdalohippocampectomy and ATL had a lower recurrence of seizures (p=0.041). 


Surgical resection in patients with TLE was associated with greater seizure freedom that did not vary over time. ATL had a lower risk of seizure recurrence over the five-year follow-up period.

Authors/Disclosures
Jimena Gonzalez Salido, MD
PRESENTER
Miss Gonzalez Salido has nothing to disclose.
Luis A. Marin-Castañeda, Sr. (INNN) Mr. Marin-Castañeda has nothing to disclose.
Jimena Colado, MD Dr. Colado has nothing to disclose.
Irving Fuentes Mr. Fuentes has nothing to disclose.
Fernando Vasquez Lopez, MD Dr. Vasquez Lopez has nothing to disclose.
Betsy C. Vazquez, MD Dr. Vazquez has nothing to disclose.
Mijail A. Rivas, Sr., MD (Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Juarez) Dr. Rivas has nothing to disclose.
Eithel A. Valenzuela Mendivil Eithel A. Valenzuela Mendivil has nothing to disclose.
Salvador Martinez-Medina, MD Dr. Martinez-Medina has nothing to disclose.
Paulina de Angoitia-Flores, Medical Student Ms. de Angoitia-Flores has nothing to disclose.
Alfonso Arellano Reynoso, MD Dr. Arellano Reynoso has nothing to disclose.
Mario Sebastian-Diaz, MD, PhD Dr. Sebastian-Diaz has nothing to disclose.
Iris E. Martinez-Juarez, MD (Instituto Nacional de Neurología y Neurocirugía) No disclosure on file